Your browser doesn't support javascript.
loading
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial.
Ito, Sadayoshi; Kashihara, Naoki; Shikata, Kenichi; Nangaku, Masaomi; Wada, Takashi; Okuda, Yasuyuki; Sawanobori, Tomoko.
Afiliação
  • Ito S; Division of Nephrology, Endocrinology and Vascular Medicine, Department of Medicine, Tohoku University School of Medicine, Sendai, Japan.
  • Kashihara N; Katta General Hospital, Shiroishi, Japan.
  • Shikata K; Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.
  • Nangaku M; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Wada T; Division of Nephrology and Endocrinology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Okuda Y; Department of Nephrology and Laboratory Medicine, Kanazawa University, Kanazawa, Japan.
  • Sawanobori T; Biostatistics and Data Management Department, Daiichi Sankyo Co., Ltd., Tokyo, Japan.
Clin J Am Soc Nephrol ; 15(12): 1715-1727, 2020 12 07.
Article em En | MEDLINE | ID: mdl-33239409
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Sulfonas / Diabetes Mellitus Tipo 2 / Albuminúria / Antagonistas de Receptores de Mineralocorticoides / Rim Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirróis / Sulfonas / Diabetes Mellitus Tipo 2 / Albuminúria / Antagonistas de Receptores de Mineralocorticoides / Rim Idioma: En Ano de publicação: 2020 Tipo de documento: Article